Collectively, these results from transcriptional profiling further advanced our observation that non-metastatic breast cancer cells can secrete more EVs than metastatic breast cancer cells, and suggest that the ALIX-Syndecan-Syntenin pathway supports this function. The gene discussed is PDCD6IP; the disease is breast cancer.